Candis Morrison - Concepedia

Author

Candis Morrison

National Cancer Institute

Also Known As

C MORRISON, C Morrison, C.A. Morrison, Candis Morrison

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Walter Reed National Military Medical Center

About

Candis Morrison is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	250
2	Health Sciences	1	1	35
3	Public Health	1	1	41
4	Biostatistics	1	1	41
5	Epidemiology	1	1	41

Candis Morrison

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma Neha Korde, Mark Roschewski, Adriana Zingone, JAMA Oncology	2015	308
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies Ian W. Flinn, John C. Byrd, Candis Morrison, Blood	2000	214
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies Ian W. Flinn, John C. Byrd, Candis Morrison, Blood	2000	191
The fate of abstracts submitted to a cancer meeting: Factors which influence presentation and subsequent publication Charterte Bellefeuille, Candis Morrison, Ian F. Tannock Annals of Oncology Cancer MeetingOncologyCancer ManagementCancer RegistrationSubsequent Publication	1992	143
Diagnostic challenges of early Lyme disease: Lessons from a community case series John N. Aucott, Candis Morrison, Beatriz Muñoz, BMC Infectious Diseases	2009	131
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, New England Journal of Medicine	2024	58
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement Yvette L. Kasamon, Richard J. Jones, Steven Piantadosi, Biology of Blood and Marrow Transplantation	2005	43
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma Sham Mailankody, Dickran Kazandjian, Neha Korde, Blood Advances	2017	43
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models Elizabeth Hill, Alexander Dew, Candis Morrison, JAMA Oncology Hematological MalignancyEpidemiologyMedicinePrognosisRisk Management	2020	41
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma Dickran Kazandjian, Elizabeth Hill, Alexander Dew, JAMA Oncology	2021	38

Page 1